CClinicalTrials.gg
Sign In
Status unknownNCT03196622SARCSAUpdated Jul 27, 2017

Validation of a Screening Test for Sarcopenia in Older People

An interventional study of Handgrip test in Sarcopenia, sponsored by University Hospital, Clermont-Ferrand. Status unknown at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2017-07-27.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jun 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,300
Allocation
Not applicable
Ages
75 Years and older
Sex
All
01

Study summary

Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia.

Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.

Read the detailed description

A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.

02

Conditions studied

  • Sarcopenia

Browse trials for

Keywords

  • Sarcopenia
  • Elderly people
  • Hospitalization
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's planned enrollment of 1,300 is above the median of 60 across 775 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≥ 75 years old

Exclusion criteria

Exclusion Criteria:

  • Palliative care,
  • Protection of vulnerable adults
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,300 participants (estimated)

Study arms

  • Experimental
    Older people

    A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.

    Device: Handgrip test

Interventions

  • DeviceHandgrip test

    Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.

06

What researchers measure

Primary outcomes

  1. Handgrip test could be used as a screening test of sarcopenia

    Time frame: at day 1

07

Study locations

1 of 1 sites recruiting
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, Auvergne 63003, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03196622
Lead sponsor
University Hospital, Clermont-Ferrand
Collaborators
Nutriset
Responsible party
Sponsor
First posted
Jun 23, 2017
Start date
Jul 11, 2017
Primary completion
Dec 2018 (estimated)
Completion
Jun 2019 (estimated)
Last update
Jul 27, 2017

Study contacts

Patrick LACARIN
Contact
placarin@chu-clermontferrand.fr
04 73 75 11 95
Marie BLANQUET
principal investigator · CHU de Clermont-Ferrand

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Sarcopenia→

Other studies from this sponsor

University Hospital, Clermont-Ferrand

Start the discussion